LIFECORE BIOMEDICAL, INC. \DE\
For the period ended Sep 30, 2026. Filed Nov 4, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 4, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Leases
- Leases
Substantially all current lease activity comes fromtwo active facilities near the Company’s owned headquarters facility in Chaska, Minnesota.
In January 2016, a lease commenced for the Company’s warehouse and final packaging building in Chaska, Minnesota. The lease has since been amended twice to accomplish the following: (i) to extend the term of the lease to September 2034, (ii) to add a purchase option equal to the balance of the lessor’s mortgage loan, valued at $3,100 as of September 30, 2026; and (iii) to provide a $2,400 cash payment to the Company in October 2024 in exchange for an increased rent payment schedule and the updated purchase option. The lease is classified as a finance lease and has a discount rate of 9%, which was the Company’s incremental borrowing rate at the time of the most recent amendment to the lease in August 2024.
In January 2021, a lease commenced for the Company’s warehouse and office space in Chanhassen, Minnesota. The lease expires in March 2028 with an option to extend through March 2033 that the Company is reasonably certain to exercise. The lease is classified as an operating lease and has a discount rate of 3%, which was the Company’s incremental borrowing rate at lease inception.
The components of lease cost were as follows:
| Nine months endedSeptember 30, | ||
|---|---|---|
| 2026 | 2025 | |
| Finance lease cost: | ||
| Amortization of leased assets | $119 | $119 |
| Interest on lease liabilities | 384 | 394 |
| Operating lease cost | 221 | 221 |
| Total lease cost | $724 | $734 |
The Company’s maturity analysis of operating and finance lease liabilities as of September 30, 2026 is as follows:
| Operatingleases · Financeleases | ||
|---|---|---|
| Remainder of 2026 | $103 | $173 |
| 2027 | 414 | 708 |
| 2028 | 144 | 725 |
| 2029 | 148 | 729 |
| 2030 | 153 | 724 |
| Thereafter | 346 | 5,973 |
| Total lease payments | 1,308 | 9,032 |
| Less: interest | (94) | (3,292) |
| Present value of lease liabilities | $1,214 | $5,740 |
| Classification on consolidated balance sheet: | ||
| Accounts payable | $383 | $— |
| Accrued expenses and other current liabilities (see note 7) | — | 205 |
| Debt, net of current portion | — | 5,535 |
| Other liabilities | 831 | — |
| Present value of lease liabilities | $1,214 | $5,740 |
Supplemental cash flow information related to leases is as follows:
| Nine months endedSeptember 30, | ||
|---|---|---|
| 2026 | 2025 | |
| Operating cash flows from operating leases | $308 | $305 |
| Operating cash flows from finance leases | 384 | 394 |
| Financing cash flows from finance leases | 135 | 113 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.